TAN, WEN SIANG
BSc (Hons) (UPM), MSc (UPM), PhD (Edinburgh), FASc
		Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
		wstan@upm.edu.my

Education and work history

Wen Siang undertook his PhD study with Prof. Sir Kenneth Murray who developed the first effective recombinant vaccine against hepatitis B virus (HBV). He is an enthusiast of phage display and virus-like particles (VLPs), as well as their practical uses in the development of multi-component vaccines, drug delivery systems and immunological reagents. His research team has developed influenza A, hepatitis B and Japanese encephalitis vaccines based on VLPs. He has established many new methods to purify the VLPs of HBV, nodavirus, Newcastle disease virus and Nipah virus. Wen Siang has also developed methods to package anti-cancer drugs in VLPs, and display ligands on their surface for specific targeted delivery to cancer cells. The methods he has introduced include the "Nano-Glue", "Add-and-Display", "pH responsive and heat-responsive VLPs" for displaying cancer ligands and specific delivery of anticancer drugs, proteins and nucleic acids into cancer cells.  In 2005, he was awarded the Norken Stiftung Research Fellowship to study structural biology in the laboratory of Prof. Malcolm Walkinshaw. In 2012, he was awarded the Top Research Scientists of Malaysia. In 2019, he was elected as a fellow of the Academy of Sciences Malaysia. In 2020, he was elected as the recipient of the Malaysian Society for Biochemistry and Molecular Biology (MSBMB) Research Excellence Award.

Orchid ID	:	https://orcid.org/0000-0001-9452-198X
Scopus ID	:	57221329387
Google ID	:	Wen Siang TAN

Updated:: 13/06/2022 [azah]